The CDC on Jan. 18 issued updated guidance for clinicians regarding exposure to per-and polyfluoroalkyl substances, urging them to consider a patient’s individual history and possible exposure to the chemicals and to order blood tests as needed to detect both recent and past exposures.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
